Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Africa

Africa

In Africa, the revenue in the Other Vaccines market is projected to reach US$0.54bn by 2024.
It is expected to show an annual growth rate of 10.51% from 2024 to 2029, resulting in a market volume of US$0.89bn by 2029.
When compared globally, United States is expected to generate the highest revenue of US$24,730.00m in 2024.
In Africa, there is a growing demand for other vaccines as the continent focuses on expanding its immunization programs.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for vaccines in Africa has been increasing over the years, with a focus on preventing diseases such as measles, polio, and yellow fever. The Other Vaccines market in Africa has also seen a steady growth rate due to the rise in awareness of the importance of vaccinations and the need for preventive measures.

Customer preferences: Customers in Africa are becoming more aware of the importance of vaccinations in preventing diseases. Governments and non-governmental organizations (NGOs) have been working together to educate the public on the benefits of vaccines. This has led to an increase in demand for vaccines, including the Other Vaccines market.

Trends in the market: The Other Vaccines market in Africa has seen a trend in the development of new vaccines for diseases such as meningitis, typhoid, and hepatitis. This has led to an increase in the availability of vaccines, which has helped to meet the growing demand. Additionally, there has been an increase in the use of combination vaccines, which offer multiple disease protection in a single shot.

Local special circumstances: Africa is a vast continent with different regions having unique health challenges. In some regions, there are challenges with access to healthcare facilities and distribution of vaccines. Governments and NGOs are working towards improving the distribution of vaccines to remote areas and increasing access to healthcare facilities.

Underlying macroeconomic factors: The economic growth in Africa has been a driver for the increasing demand for vaccines. As the economies of African countries grow, there is an increase in the middle-class population, which has led to an increase in demand for healthcare services. Additionally, the rise in government spending on healthcare has led to an increase in the availability of vaccines.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.